دورية أكاديمية
A randomized study of KRAS-guided maintenance therapy with bevacizumab, erlotinib or metronomic capecitabine after first-line induction treatment of metastatic colorectal cancer: the Nordic ACT2 trial
| العنوان: | A randomized study of KRAS-guided maintenance therapy with bevacizumab, erlotinib or metronomic capecitabine after first-line induction treatment of metastatic colorectal cancer: the Nordic ACT2 trial |
|---|---|
| المؤلفون: | Hagman, H. *, Frödin, J.-E., Berglund, Å., Sundberg, J., Vestermark, L.W., Albertsson, M., Fernebro, E., Johnsson, A. |
| المصدر: | In Annals of Oncology January 2016 27(1):140-147 |
| قاعدة البيانات: | ScienceDirect |
| تدمد: | 09237534 |
|---|---|
| DOI: | 10.1093/annonc/mdv490 |